Thomas White International Ltd. Has $408,000 Stake in Danaher Corporation (DHR)
Thomas White International Ltd. maintained its stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 4,830 shares of the conglomerate’s stock at the close of the 2nd quarter. Thomas White International Ltd.’s holdings in Danaher Corporation were worth $408,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Peddock Capital Advisors LLC increased its stake in Danaher Corporation by 17.4% during the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 181 shares during the last quarter. Proficio Capital Partners LLC increased its stake in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares during the last quarter. ClariVest Asset Management LLC bought a new stake in Danaher Corporation during the first quarter valued at $157,000. Motco increased its stake in Danaher Corporation by 8.8% during the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock valued at $170,000 after purchasing an additional 163 shares during the last quarter. Finally, Cornerstone Advisors Inc. increased its stake in Danaher Corporation by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock valued at $178,000 after purchasing an additional 808 shares during the last quarter. Institutional investors and hedge funds own 75.68% of the company’s stock.
Danaher Corporation (DHR) opened at 86.97 on Friday. The firm has a market cap of $60.42 billion, a P/E ratio of 27.76 and a beta of 1.03. The stock’s 50 day moving average is $84.88 and its 200 day moving average is $84.18. Danaher Corporation has a one year low of $75.71 and a one year high of $88.62.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.90 earnings per share. On average, equities research analysts expect that Danaher Corporation will post $3.95 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s payout ratio is presently 17.83%.
In other news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the sale, the director now owns 42,151 shares in the company, valued at $3,499,797.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William King sold 7,458 shares of the stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the sale, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock worth $5,916,223 in the last 90 days. Company insiders own 12.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Thomas White International Ltd. Has $408,000 Stake in Danaher Corporation (DHR)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/thomas-white-international-ltd-has-408000-stake-in-danaher-corporation-dhr/1611731.html.
DHR has been the subject of several recent research reports. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, September 8th. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $88.00 target price on shares of Danaher Corporation in a research note on Wednesday, July 12th. One research analyst has rated the stock with a sell rating, four have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Danaher Corporation presently has an average rating of “Buy” and a consensus target price of $92.44.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.